{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:22:36Z","timestamp":1789806156462,"version":"4.0.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.bbmt.2019.12.003","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T04:55:14Z","timestamp":1575867314000},"page":"e65-e73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Use of Thrombopoietin Receptor Agonists in Prolonged Thrombocytopenia after Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"26","author":[{"given":"Upendra","family":"Mahat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth J.","family":"Rotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabi","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.12.003_bib0001","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bbmt.2015.07.032","article-title":"Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation","volume":"21","author":"Majhail","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0002","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.bmt.1704330","article-title":"Prognostic importance of the platelet count 100 days post-allogeneic bone marrow transplant","volume":"33","author":"Bolwell","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0003","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/leu.2011.257","article-title":"Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study","volume":"26","author":"Kuzmina","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0004","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood.V65.2.368.368","article-title":"Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes","volume":"65","author":"First","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood.V72.2.546.546","article-title":"Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation","volume":"72","author":"Sullivan","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0006","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/bbmt.2003.50003","article-title":"Chronic graft-versus-host disease: a prospective cohort study","volume":"9","author":"Arora","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0007","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1634\/theoncologist.1-6-371","article-title":"The problem of thrombocytopenia after hematopoietic stem cell transplantation","volume":"1","author":"Nash","year":"1996","journal-title":"Oncologist"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0008","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/sj.bmt.1705444","article-title":"Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover","volume":"38","author":"Yamazaki","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0009","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/bbmt.2001.v7.pm11302549","article-title":"Secondary failure of platelet recovery after hematopoietic stem cell transplantation","volume":"7","author":"Bruno","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0010","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0092-8674(90)90410-G","article-title":"A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors","volume":"63","author":"Souyri","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0011","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1073\/pnas.89.12.5640","article-title":"Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily","volume":"89","author":"Vigon","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0012","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/blood.V85.2.391.391","article-title":"The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets","volume":"85","author":"Debili","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0013","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0092-8674(94)90450-2","article-title":"Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl","volume":"77","author":"Bartley","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0014","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/369533a0","article-title":"Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand","volume":"369","author":"de Sauvage","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0015","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1073\/pnas.91.23.11104","article-title":"The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production","volume":"91","author":"Kuter","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0016","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/369565a0","article-title":"Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo","volume":"369","author":"Lok","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0017","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(94)01008-0","article-title":"Molecular cloning and chromosomal localization of the human thrombopoietin gene","volume":"353","author":"Sohma","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0018","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V85.4.981.bloodjournal854981","article-title":"Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin","volume":"85","author":"Gurney","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0019","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1538-7836.2003.00273.x","article-title":"Thrombopoietin: a tool for understanding thrombopoiesis","volume":"1","author":"Kaushansky","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0020","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1073\/pnas.0308530100","article-title":"Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment","volume":"101","author":"Feese","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0021","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/bjh.12772","article-title":"Thrombopoietin from beginning to end","volume":"165","author":"Hitchcock","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0022","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1055\/s-0037-1615024","article-title":"Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations","volume":"79","author":"Koike","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0023","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1182\/blood.V87.6.2154.bloodjournal8762154","article-title":"Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets","volume":"87","author":"Fielder","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0024","first-page":"478","article-title":"The physiological response of thrombopoietin (c-Mpl ligand) to thrombocytopenia in the rat","volume":"105","author":"Yang","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0025","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3324\/haematol.2010.030536","article-title":"Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes","volume":"96","author":"Feng","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0026","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2141.1998.00590.x","article-title":"Thrombopoietin serum levels in patients with aplastic anaemia: correlation with platelet count and persistent elevation in remission","volume":"100","author":"Schrezenmeier","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0027","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/0973-6247.150956","article-title":"Circulating thrombopoietin levels in normal healthy blood donors and in aplastic anemia patients in relation to disease severity","volume":"9","author":"Singh","year":"2015","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0028","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1055\/s-0038-1650641","article-title":"Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura","volume":"76","author":"Mukai","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0029","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.leu.2400946","article-title":"Serum thrombopoietin levels in patients correlate inversely with platelet counts during chemotherapy-induced thrombocytopenia","volume":"12","author":"Shinjo","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0030","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1046\/j.1365-2141.1998.00747.x","article-title":"Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes","volume":"101","author":"Hou","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0031","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12185-015-1806-0","article-title":"Identification of anti-thrombopoietin receptor antibody in prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation treated successfully with eltrombopag","volume":"102","author":"Fujimi","year":"2015","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0032","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1182\/blood.V87.10.4068.bloodjournal87104068","article-title":"Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction","volume":"87","author":"Emmons","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0033","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1055\/s-0038-1656057","article-title":"Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis","volume":"77","author":"Nagata","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0034","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1365-2141.1998.00683.x","article-title":"Serum thrombopoietin level is mainly regulated by megakaryocyte mass rather than platelet mass in human subjects","volume":"101","author":"Nagasawa","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2141.1997.3823196.x","article-title":"Thrombopoietin levels in patients with primary and reactive thrombocytosis","volume":"99","author":"Cerutti","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0036","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1034\/j.1600-0676.2002.01547.x","article-title":"Thrombopoietin serum levels are elevated in patients with hepatitis B\/C infection compared to other causes of chronic liver disease","volume":"22","author":"Sch\u00f6ffski","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0037","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1034\/j.1600-0676.2002.01574.x","article-title":"Thrombopoietin serum levels do not correlate with thrombocytopenia in hepatic schistosomiasis","volume":"22","author":"Souza","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0038","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1034\/j.1600-0676.2002.01642.x","article-title":"Quantification of hepatic thrombopoietin mRNA transcripts in patients with chronic liver diseases shows maintained gene expression in different etiologies of liver cirrhosis","volume":"22","author":"Tacke","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0039","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood.V92.1.46.413k44_46_52","article-title":"Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cells","volume":"92","author":"Hirayama","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0040","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1182\/blood.V98.9.2720","article-title":"Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis","volume":"98","author":"Kaser","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0041","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI113060","article-title":"Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance","volume":"80","author":"Ballem","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0042","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood.V98.12.3241","article-title":"Thrombocytopenia caused by the development of antibodies to thrombopoietin","volume":"98","author":"Li","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0043","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood.V99.7.2599","article-title":"Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor","volume":"99","author":"Basser","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0044","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1182\/blood.V100.10.3457","article-title":"Recombinant human thrombopoietin: basic biology and evaluation of clinical studies","volume":"100","author":"Kuter","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0045","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","article-title":"Eltrombopag added to standard immunosuppression for aplastic anemia","volume":"376","author":"Townsley","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0046","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","article-title":"Thrombopoietin receptor agonists: ten years later","volume":"104","author":"Ghanima","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0047","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cyto.2003.05.001","article-title":"AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl","volume":"25","author":"Broudy","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0048","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1634\/stemcells.2008-0366","article-title":"Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist","volume":"27","author":"Erickson-Miller","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0049","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1182\/blood-2009-04-219493","article-title":"Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome","volume":"114","author":"Will","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0050","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3324\/haematol.2013.098921","article-title":"Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up","volume":"99","author":"Ghanima","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0051","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000452992","article-title":"A 2-year, longitudinal, prospective study of the effects of eltrombopag on bone marrow in patients with chronic immune thrombocytopenia","volume":"137","author":"Brynes","year":"2017","journal-title":"Acta Haematol"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0052","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/ejh.12181","article-title":"Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials","volume":"91","author":"Rodeghiero","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0053","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/bbmt.2001.v7.abbmt070239","article-title":"Use of screening studies to predict survival among patients who do not have chronic graft-versus-host disease at day 100 after bone marrow transplantation","volume":"7","author":"Wagner","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0054","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1083-8791(00)70049-8","article-title":"A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation","volume":"6","author":"Nash","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0055","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00277-015-2440-x","article-title":"The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantation","volume":"94","author":"Sun","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0056","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/s41409-019-0435-2","article-title":"Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation","volume":"54","author":"Fu","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0057","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1182\/blood.V73.4.1054.1054","article-title":"Graft-v-host disease is associated with autoimmune-like thrombocytopenia","volume":"73","author":"Anasetti","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0058","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.bbmt.2016.06.003","article-title":"Risk factors and impact of secondary failure of platelet recovery after allogeneic stem cell transplantation","volume":"22","author":"Akahoshi","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0059","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJM199310213291703","article-title":"Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease","volume":"329","author":"Chao","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.bmt.1702221","article-title":"Thrombopoietic cytokines in relation to platelet recovery after bone marrow transplantation","volume":"25","author":"Weisdorf","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0061","doi-asserted-by":"crossref","first-page":"13017","DOI":"10.1111\/petr.13017","article-title":"Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children","volume":"21","author":"Ali","year":"2017","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0062","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/tme.12300","article-title":"Eltrombopag after allogeneic haematopoietic cell transplantation in a case of poor graft function and systematic review of the literature","volume":"26","author":"Dyba","year":"2016","journal-title":"Transfus Med"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0063","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41409-019-0442-3","article-title":"Eltrombopag for post-transplant cytopenias due to poor graft function","volume":"54","author":"Marotta","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0064","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000487229","article-title":"Use of eltrombopag in improving poor graft function after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Master","year":"2018","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12288-014-0491-0","article-title":"Safety and efficacy of eltrombopag in post-hematopoietic stem cell transplantation (HSCT) thrombocytopenia","volume":"31","author":"Raut","year":"2015","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0066","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41409-018-0368-1","article-title":"Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation","volume":"54","author":"Rivera","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0067","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbmt.2016.01.018","article-title":"Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation","volume":"22","author":"Tanaka","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0068","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-018-0649-6","article-title":"Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag","volume":"11","author":"Tang","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0069","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.bbmt.2019.01.027","article-title":"Eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation","volume":"25","author":"Yuan","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0070","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ajh.23225","article-title":"Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia","volume":"87","author":"Reid","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0071","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/ijc.25862","article-title":"Childhood Hodgkin's lymphoma, non-Hodgkin's lymphoma and factors related to the immune system: the Escale Study (SFCE)","volume":"129","author":"Rudant","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0072","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1078155215612240","article-title":"Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients","volume":"23","author":"Hartranft","year":"2017","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0073","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/bmt.2011.179","article-title":"Romiplostim (AMG531, Nplate) for secondary failure of platelet recovery after allo-SCT","volume":"46","author":"Calmettes","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0074","doi-asserted-by":"crossref","unstructured":"Lancman G, Coltoff A, Steinberg A. Romiplostim for thrombocytopenia following allogeneic stem cell transplantation: a case series [e-pub ahead of print]. Hematol Oncol Stem Cell Ther. doi:10.1016\/j.hemonc.2018.07.002.","DOI":"10.1016\/j.hemonc.2018.07.002"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0075","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/bmt.2015.182","article-title":"Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation","volume":"50","author":"Battipaglia","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0076","doi-asserted-by":"crossref","first-page":"E181","DOI":"10.1111\/petr.12564","article-title":"Successful treatment of secondary graft failure following unrelated cord blood transplant with hematopoietic growth factors in a pediatric patient with Fanconi anemia","volume":"19","author":"Buchbinder","year":"2015","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0077","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12185-015-1821-1","article-title":"Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children","volume":"102","author":"Maximova","year":"2015","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0078","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1111\/petr.12325","article-title":"Successful treatment of post-transplant thrombocytopenia with romiplostim in a pediatric patient with X-linked chronic granulomatous disease","volume":"18","author":"Buchbinder","year":"2014","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0079","first-page":"260","article-title":"Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation","volume":"3","author":"Poon","year":"2013","journal-title":"Am J Blood Res"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0080","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/1078155212469640","article-title":"Romiplostim resistance in secondary failure of platelet recovery","volume":"19","author":"DeRemer","year":"2013","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0081","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/bmt.2010.298","article-title":"Persistent thrombocytopenia post auto-SCT for AML treated with romiplostim in a patient with HIV","volume":"46","author":"Gangatharan","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0082","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/pbc.22332","article-title":"Response of refractory immune thrombocytopenia after bone marrow transplantation to romiplostim","volume":"54","author":"Beck","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2019.12.003_bib0083","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0609.2012.01832.x","article-title":"Response of complex immune-mediated thrombocytopenia to romiplostim in the setting of allogeneic stem cell transplantation for chronic myelogenous leukemia","volume":"89","author":"Bollag","year":"2012","journal-title":"Eur J Haematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119308389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119308389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:10:11Z","timestamp":1761059411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119308389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1083879119308389"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.12.003","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Thrombopoietin Receptor Agonists in Prolonged Thrombocytopenia after Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}